Oculis Holding AG (OCS) Other Non Operating Income (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Other Non Operating Income of $724061.7 in Q1 2026, up 496.61% quarter-over-quarter from $121363.5 in Q4 2025, and up 141.54% on a YoY basis from $299764.4 in Q1 2025.
Oculis Holding AG (OCS) Other Non Operating Income (2022 - 2026) Analysis & Trends
Oculis Holding AG's Other Non Operating Income history runs 5 years deep, the most recent figure standing at $724061.7 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 141.54% year-over-year to $724061.7; the TTM figure through Mar 2026 stood at $2.5 billion (up 213.18% YoY), while the FY2025 annual figure was -$7.6 million, down 628.08% from the prior year.
- Other Non Operating Income was $724061.7 for Q1 2026 at Oculis Holding AG, up from $121363.5 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.5 billion in Q3 2025 to a low of -$2.2 billion in Q3 2024.
- Historically, Other Non Operating Income has averaged $17.8 million across 5 years, with a median of -$278984.7 in 2023.
- Biggest YoY gain for Other Non Operating Income was 882.33% in 2024; the steepest drop was 72670.47% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $3.3 million in 2022, then slumped by 174.35% to -$2.5 million in 2023, then surged by 175.75% to $1.9 million in 2024, then sank by 93.48% to $121363.5 in 2025, then surged by 496.61% to $724061.7 in 2026.
- The last three Other Non Operating Income figures came in at $724061.7 (Q1 2026), $121363.5 (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,061.65 |
| Dec 31, 2025 | 121,363.47 |
| Sep 30, 2025 | 2.47 Bn |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | -2.18 Bn |
| Jun 30, 2024 | -295,246.86 |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | -2.46 Mn |
| Sep 30, 2023 | -2.99 Mn |
| Jun 30, 2023 | 453,767.62 |
| Mar 31, 2023 | -262,722.51 |
| Dec 31, 2022 | 3.30 Mn |
| Sep 30, 2022 | -1.35 Mn |
| Jun 30, 2022 | -1.46 Mn |